From: An integrated transcriptome and expressed variant analysis of sepsis survival and death
Clinical variable | SIRS | Sepsis survivors | Sepsis non-survivors |
---|---|---|---|
n | 23 | 78 | 28 |
Age (years) | 64.9 ± 14.4 | 56.1 ± 18.0 | 67.6 ± 17.0 |
Gender (% Male) | 34.8% | 59.0% | 60.7% |
Race (B/W/O) | 16/6/1 | 47/26/5 | 21/6/1 |
APACHE II | 16.8 ± 7.7 | 14.7 ± 6.6 | 21.3 ± 7.1 |
Pathogena | Â | Â | Â |
S. aureus | N/A | 20 (26%) | 5 (18%) |
S. pneumoniae | N/A | 20 (26%) | 4 (14%) |
Enterobacteriaceae | N/A | 23 (29%) | 3 (11%) |
Total leukocyte countb | 11.2 (8.8, 13.5) | 14.6 (9.7, 18.7) | 15.1 (10.4, 21.9) |
% Neutrophils | 77.0 (73.5, 83.3) | 85.0 (82.0, 91.0) | 87.4 (82.0, 92.8) |
% Lymphocytes | 13.0 (7.6, 15.8) | 7.0 (4.0, 11.0) | 8.0 (4.2, 11.8) |
% Monocytes | 7.1 (4.4, 9.8) | 5.0 (3.0, 8.0) | 4.5 (2.0, 6.0) |
Co-morbidities | Â | Â | Â |
Alcohol abuse | 17.4% | 17.9% | 10.7% |
Neoplastic disease | 13.0% | 6.4% | 21.4% |
Diabetes | 30.4% | 32.1% | 35.7% |
Congestive heart failure | 0% | 6.4% | 14.3% |
Chronic kidney disease | 26.1% | 21.8% | 25.0% |
Chronic liver disease | 8.7% | 5.1% | 21.4% |
Immunosuppression | 0% | 6.4% | 7.1% |
Smoker | 21.7% | 30.8% | 25.0% |